Answers are grounded in this paper and cite their sources.
These recommendations provide sponsors and investigators with methods of improving diversity and inclusivity of clinical trial populations in MS.
No takes yet. Share an insight, caveat, or question.
Marrie et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: